Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
25.40
+0.62 (2.50%)
Sep 2, 2026, 10:08 AM EDT - Market open
Caris Life Sciences Revenue
Caris Life Sciences had revenue of $263.71M in the quarter ending June 30, 2026, with 45.38% growth. This brings the company's revenue in the last twelve months to $989.61M, up 85.37% year-over-year. In the year 2025, Caris Life Sciences had annual revenue of $812.03M with 96.97% growth.
Revenue (ttm)
$989.61M
Revenue Growth
+85.37%
P/S Ratio
7.08
Revenue / Employee
$536,081
Employees
1,846
Market Cap
7.18B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 812.03M | 399.77M | 96.97% |
| Dec 31, 2024 | 412.26M | 106.13M | 34.67% |
| Dec 31, 2023 | 306.13M | 47.64M | 18.43% |
| Dec 31, 2022 | 258.49M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
CAI News
- 1 hour ago - Caris Life Sciences to present new research at IASCL 2026 - TheFly
- 26 days ago - Caris Life Sciences price target raised to $33 from $32 at BTIG - TheFly
- 27 days ago - Caris Life Sciences price target raised to $26 from $25 at Evercore ISI - TheFly
- 27 days ago - Caris Life Sciences reports Q2 EPS 0c, consensus 1c - TheFly
- 27 days ago - Caris Life Sciences sees 2026 revenue $1.03B-$1.04B, consensus $”This was a reco - TheFly
- 27 days ago - Caris Life Sciences Earnings Call Transcript: Q2 2026 - Transcripts
- 27 days ago - Caris Life Sciences Earnings release: Q2 2026 - Filings
- 27 days ago - Caris Life Sciences Slides: Q2 2026 - Filings